MEDPLUS · Healthcare · Pharmaceutical Retailers
Composite scorecard: 34/100 — Quality 29 · Valuation 47 · Momentum 27
| Share price | ₹801.30 |
| Market cap | ₹9,920 Cr |
| P/E ratio | 45.2 |
| P/B ratio | 5.0 |
| ROCE | 12.2% |
| Book value | ₹164.55 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹6,892 Cr | ₹220 Cr | 9.0% |
| 2025 | ₹6,136 Cr | ₹150 Cr | 8.0% |
| 2024 | ₹5,625 Cr | ₹66 Cr | 6.0% |
| 2023 | ₹4,558 Cr | ₹50 Cr | 6.0% |
| 2022 | ₹3,779 Cr | ₹95 Cr | 7.0% |
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private